PFGIA
VNDA icon

Patriot Financial Group Insurance Agency’s Vanda Pharmaceuticals VNDA Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-9
Closed – – 2004
2020
Q3 		$0 Hold
9
– – ﹤0.01% 1857
2020
Q2 		$0 Buy
+9
New +$102 ﹤0.01% 1850

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Patriot Financial Group Insurance Agency's VNDA Position: Q4 2020 in Review

Patriot Financial Group Insurance Agency sold out of Vanda Pharmaceuticals (VNDA) in Q4 2020, closing a stake of 9 shares.

Patriot Financial Group Insurance Agency first reported a position in VNDA in Q2 2020 and held it in 2 quarters. The position peaked at $0 in Q3 2020. 178 funds tracked by Wall St. Rank hold VNDA as of Q4 2020.

  • Patriot Financial Group Insurance Agency reported no remaining Vanda Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 9 Vanda Pharmaceuticals shares in Q4 2020.
  • Patriot Financial Group Insurance Agency first reported a position in Vanda Pharmaceuticals in Q2 2020 and held it in 2 quarters.
  • Patriot Financial Group Insurance Agency's Vanda Pharmaceuticals position peaked at $0 in Q3 2020.
  • 178 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2020.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q4 2020, filed 15 Jan 2021.